Skip to content

MDMA research published in 2014

Page 2 of 4: studies 21 to 40 of 78, newest first. Back to the MDMA overview

Studies

Effects of ecstasy on cooperative behaviour and perception of trustworthiness: A naturalistic study

Journal of Psychopharmacology August 13, 2014 LH Stewart, Bart Ferguson, CJA Morgan et al. 28 citations

BACKGROUND: Acute recreational use of 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') can promote pro-social effects which may alter interpersonal perceptions. AIMS: To explore such effects, this study investigated whether acute recreational use of ecstasy was associated with changes in individual perception of trustworthiness of people's faces and co-operative behaviours. METHOD: An...

The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum.

Pharmacological Reports August 2014 Anna Maria Górska, Karolina Noworyta-Sokołowska, Krystyna Gołembiowska

The psychostimulant 3,4-methylenedioxymethamphetamine (MDMA) with a strong addictive potential is widely used as a recreational drug. Neurotoxicity of MDMA is related with the generation of highly reactive free radicals. MDMA was given in doses of 20 and 40mg/kg ip alone or in combination with caffeine (CAF) 10mg/kg ip. Extracellular concentration of hydroxyl radical was measured using...

Strategic control, consolidation and poly-drug use; the relative contributions to verbal memory impairment in recreational ecstasy users

UTAS Research Repository August 1, 2014 Emma Rouse

Tests of verbal learning and memory have frequently been used to examine memory performance in frequent 3,4-methylendioxymethamphetamine (ecstasy‚ÄövÑvp) consumers, and meta-analyses have identified verbal learning and memory as the cognitive domain most adversely affected by regular ecstasy use (eg. Kalechstein, et al., 2007; Zakzanis, Campbell & Jovanovski, 2007). Tests of verbal memory are...

Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.

Journal of Pharmacology and Experimental Therapeutics August 2014 Tomohisa Mori, Naoki Uzawa, Haruyo Kazawa et al.

Previous studies have demonstrated that methylphenidate, MDMA (3,4-methylenedioxymethamphetamine), and other psychostimulants exert stimulant-like subjective effects in humans. Furthermore, MDMA and methylphenidate substitute for the discriminative stimulus effects of psychostimulants, such as amphetamine and cocaine, in animals, which suggests that MDMA and methylphenidate may produce similar...

Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.

European Neuropsychopharmacology August 2014 Ruud P. W. Litjens, Tibor M Brunt, Gerard-Jan Alderliefste et al.

Hallucinogen persisting perception disorder (HPPD) is a drug-induced condition associated with inaccurate visual representations. Since the underlying mechanism(s) are largely unknown, this review aims to uncover aspects underlying its etiology. Available evidence on HPPD and drug-related altered visual processing was reviewed and the majority of HPPD cases were attributed to drugs with...

MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner.

Archives of Toxicology August 2014 Daniel José Barbosa, Roman Serrat, Serena Mirra et al.

Identification of the mechanisms by which drugs of abuse cause neuronal dysfunction is essential for understanding the biological bases of their acute and long-lasting effects in the brain. Here, we performed real-time functional experiments of axonal transport of mitochondria to explore the role of in situ mitochondrial dysfunction in 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy")-related...

Differential effects of MDMA and methylphenidate on social cognition

Journal of Psychopharmacology July 22, 2014 Yasmin Schmid, Cédric M. Hysek, Linda D. Simmler et al. 154 citations

Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown. We investigated the acute effects of MDMA (75 mg), methylphenidate (40 mg) and placebo using the Facial Emotion Recognition Task, Multifaceted Empathy...

Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users

International Journal of Drug Policy July 15, 2014 Hanna Uosukainen, Ulrich Tacke, Adam Winstock 55 citations

BackgroundEvidence regarding MDMA (ecstasy) dependence and the most suitable criteria for its assessment are controversial. This study aimed to assess the prevalence of last year symptoms of dependence upon MDMA compared to cocaine, mephedrone and ketamine among a large global non-treatment seeking sample.MethodsA cross-sectional anonymous online survey was promoted by a UK-based dance music...

MDMA, cortisol, and heightened stress in recreational ecstasy users

Behavioural Pharmacology July 11, 2014 A. C. Parrott, Catharine Montgomery, Mark Wetherell et al. 34 citations

Stress develops when an organism requires additional metabolic resources to cope with demanding situations. This review will debate how recreational 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') can increase some aspects of acute and chronic stress in humans. Laboratory studies on the acute effects of MDMA on cortisol release and neurohormone levels in drug-free regular ecstasy/MDMA users...

3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder.

Annals of Pharmacotherapy July 2014 C Michael White

Review the current literature assessing the role of 3,4-methylenedioxymethamphetamine (MDMA) on posttraumatic stress disorder (PTSD). OVID MEDLINE search (1960-February 2014) using the terms MDMA, 3,4-methylenedioxymethamphetamine, Molly, and Ecstasy crossed with posttraumatic stress disorder with backwards citation tracking using references from procured articles. English language studies...

Awash in a sea of ‘bath salts’: implications for biomedical research and public health

Addiction July 1, 2014 Michael H. Baumann 49 citations

The emergence of ‘bath salts’ products containing synthetic cathinones represents a global public health threat. Synthetic cathinones have significant abuse potential, and the effects of high-dose administration can be life-threatening. More preclinical and human research is needed to understand the complex pharmacology and toxicology of these substances. During the past several years, there...

Adolescent MDMA exposure diminishes the physiological and neurotoxic consequences of an MDMA binge in female rats

Developmental Psychobiology July 1, 2014 Brian J. Piper, Christina S. Henderson, Jerrold S. Meyer 2 citations

AbstractIntermittent MDMA pretreatment blocked the reductions in serotonin transporter (SERT) binding induced by an MDMA binge in a prior study in adolescent male rats. The objective of this investigation was to determine if the physiological, behavioral, and neurochemical responses to MDMA are sexually dimorphic. Female Sprague–Dawley rats received MDMA (10 mg/kg × 2) or Saline on every fifth...

No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation

PLoS One June 27, 2014 Kim P. C. Kuypers, Rafael de la Torre, Magı́ Farré et al. 88 citations

The present study aimed at investigating the effect of MDMA on measures of empathy and social interaction, and the roles of oxytocin and the 5-HT1A receptor in these effects. The design was placebo-controlled within-subject with 4 treatment conditions: MDMA (75 mg), with or without pindolol (20 mg), oxytocin nasal spray (40 IU+16 IU) or placebo. Participants were 20 healthy poly-drug MDMA...

DOI: 10.1371/journal.pone.0100719 (opens in new tab) MDMA Empathy Pindolol Oxytocin receptor +3

Molecular basis of the selective binding of MDMA enantiomers to the alpha4beta2 nicotinic receptor subtype: synthesis, pharmacological evaluation and mechanistic studies.

European journal of medicinal chemistry June 23, 2014 Salomé Llabrés, Sara Garcia-Ratés, Edgar Cristóbal-Lecina et al.

The α4β2 nicotinic acetylcholine receptor (nAChR) is a molecular target of 3,4-methylenedioxymethamphetamine (MDMA), a synthetic drug also known as ecstasy, and it modulates the MDMA-mediated reinforcing properties. However, the enantioselective preference of the α4β2 nAChR subtype still remains unknown. Since the two enantiomers exhibit different pharmacological profiles and stereoselective...

DOI: 10.1016/j.ejmech.2014.04.044 (opens in new tab) Full text (opens in new tab) MDMA Alpha4beta2 nicotinic receptor Enantioselective binding Molecular modelling +2

Rapidly reversible multiorgan failure after ingestion of “Molly” (pure 3,4-methylenedioxymethamphetamine): a case report

Journal of Medical Case Reports June 18, 2014 Trupti Vakde, M. Díaz, Kalpana Uday et al. 16 citations

Introduction“Molly” is a street name for pure 3,4-methylenedioxymethamphetamine, an amphetamine derivative which acts by enhancing the release of neurotransmitters such as serotonin, dopamine and norepinephrine. This produces euphoria, increased sensory awareness and central stimulation that make it a popular club drug. Nevertheless, it is also associated with serious side effects. We report an...

Critical Role of Peripheral Vasoconstriction in Fatal Brain Hyperthermia Induced by MDMA (Ecstasy) under Conditions That Mimic Human Drug Use

Journal of Neuroscience June 4, 2014 Eugene A. Kiyatkin, A. H. Kim, Ken T. Wakabayashi et al. 47 citations

MDMA (Ecstasy) is an illicit drug used by young adults at hot, crowed "rave" parties, yet the data on potential health hazards of its abuse remain controversial. Here, we examined the effect of MDMA on temperature homeostasis in male rats under standard laboratory conditions and under conditions that simulate drug use in humans. We chronically implanted thermocouple microsensors in the nucleus...

Mixtures of 3,4‐methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non‐cytotoxic concentrations

Journal of Applied Toxicology June 1, 2014 Diana Dias Da Silva, Elisabete Silva, Félix Carvalho et al.

ABSTRACT: Hepatic injury after 3,4‐methylenedioxymethamphetamine (MDMA; ecstasy) intoxications is highly unpredictable and does not seem to correlate with either dosage or frequency of use. The mechanisms involved include the drug metabolic bioactivation and the hyperthermic state of the liver triggered by its thermogenic action and exacerbated by the environmental circumstances of abuse at hot...

Antagonism of Adenosine A 1 or A 2A Receptors Amplifies the Effects of MDMA on Glial Activation in the Mouse Brain: Relevance to Caffeine–MDMA Interactions

Journal of Caffeine Research June 1, 2014 Amit Khairnar, Lucia Frau, Antonio Plumitallo et al.

Background: Previous studies by our group have demonstrated that caffeine, an antagonist of adenosine A 1 and A 2A receptors, amplifies the glial activation induced by 3,4-methylendioxymethamphetamine (MDMA, “ecstasy”) in mice. To elucidate the mechanisms underlying this effect, the present study evaluated whether selective antagonists for the A 1 or the A 2A adenosine receptor had any...

Effects of MDMA and Intranasal oxytocin on social and emotional processing.

Neuropsychopharmacology June 2014 Matthew G. Kirkpatrick, Royce Lee, Margaret C. Wardle et al.

MDMA (± 3,4-methylenedioxymethamphetamine, 'ecstasy') is used recreationally, reportedly because it increases feelings of empathy, sociability, and interpersonal closeness. One line of evidence suggests that MDMA produces these effects by releasing oxytocin, a peptide involved in social bonding. In the current study, we investigated the acute effects of MDMA and oxytocin on social and emotional...

The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations.

Toxicological sciences : an official journal of the Society of Toxicology June 2014 Daniel José Barbosa, Roman Serrat, Serena Mirra et al.

3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") is a potentially neurotoxic recreational drug of abuse. Though the mechanisms involved are still not completely understood, formation of reactive metabolites and mitochondrial dysfunction contribute to MDMA-related neurotoxicity. Neuronal mitochondrial trafficking, and their targeting to synapses, is essential for proper neuronal function and...

DOI: 10.1093/toxsci/kfu042 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA MDMA'S Metabolites Mitochondrial dysfunction Mitochondrial fusion/fission +2